Are all true about staing of Beta blocker therapy in patients with congestive hea failure except
Clinical use of Beta adrenergic receptors antagonists in hea failure These are now recommended for routine use in patient with an ejection fraction <35% and NYHA class 2 and 3 symptoms in conjunction with ACE inhibitors or Angiotensin antagonist receptors and diuretics This should be initiated at very low doses, generally less than one tenth of the final target dose Goodman and Gilman 11e p1336
They should be staed with optimum doses
They should be gradually increase over a weeks
Special classes should be taken in the case of NYHA class 3 and 4
Carvedilol and metaprolol are the preferred drugs
Cardiovascular system